These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25453800)

  • 81. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
    Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
    Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study.
    Kim M; Lee S; Park EB; Kim KJ; Lee HH; Shin JS; Fischer K; Koeberle A; Werz O; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2016 Jan; 26(1):94-9. PubMed ID: 26602278
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
    Koeberle A; Siemoneit U; Bühring U; Northoff H; Laufer S; Albrecht W; Werz O
    J Pharmacol Exp Ther; 2008 Sep; 326(3):975-82. PubMed ID: 18550688
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synthesis and PGE₂ production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells.
    Kang SM; Lee J; Jin JH; Kim M; Lee S; Lee HH; Shin JS; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5418-22. PubMed ID: 25453800
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer.
    Rådmark O; Samuelsson B
    J Intern Med; 2010 Jul; 268(1):5-14. PubMed ID: 20497297
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prostaglandin E(2) synthase inhibition as a therapeutic target.
    Iyer JP; Srivastava PK; Dev R; Dastidar SG; Ray A
    Expert Opin Ther Targets; 2009 Jul; 13(7):849-65. PubMed ID: 19530988
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pyrazolotriazines: Biological activities, synthetic strategies and recent developments.
    Alizadeh SR; Ebrahimzadeh MA
    Eur J Med Chem; 2021 Nov; 223():113537. PubMed ID: 34147747
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review.
    Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ
    Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395
    [TBL] [Abstract][Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.